Randomized, placebo‐controlled, double‐blind glycemic control trial of novel sodium‐dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus
2013 ◽
Vol 5
(4)
◽
pp. 382-391
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 14
(11)
◽
pp. 1040-1046
◽
Keyword(s):
2013 ◽
Vol 15
(5)
◽
pp. 432-440
◽
2016 ◽
Vol 55
(22)
◽
pp. 3239-3245
◽
Keyword(s):
2015 ◽
Vol 17
(12)
◽
pp. 1198-1201
◽
2008 ◽
Vol 69
(4)
◽
pp. 364-377
◽
Keyword(s):
2015 ◽
Vol 7
(3)
◽
pp. 366-373
◽